Client login Menu Sir Allen McClay Home / Sir Allen McClay About A unique culture delivering exceptional solutions Our Locations Careers Post-Brexit: The Almac Advantage Innovative solutions for Biopharma and Biotech News Events Knowledge Centre Contact Us Client Login Sir Allen McClay Founder & Chairman of Almac Group (21 March 1932 – 12 January 2010) Northern Ireland lost its most passionate, visionary and generous man. Sir Allen McClay (Allen, as he preferred to be called) passed away on Tuesday 12th January, 2010 after a short illness. Allen founded his first company, Galen Ltd, in 1968. Galen floated on the stock market in 1997 and subsequently became Northern Ireland’s first £1 billion company. However, around the year 2000 the direction of the company changed and took a different path to Allen’s vision. Allen therefore realised his substantial shareholding and formed, with his personal wealth, the organisation we now know as Almac Group. Allen was totally committed to the organisation he had built and referred frequently to his “Almac family”. As part of his generosity he established the McClay Foundation as a charitable institution and has already donated in excess of £20 million to enhance the research capabilities at the Queen’s University of Belfast. In order to appreciate the high esteem in which Allen was held within the world of business and politics, refer to the numerous tributes. The greatest tribute that Almac, as a company, will pay to Allen is to continue with his passion and to deliver on his vision: “To be the leader in the generation of superior solutions for the advancement of human health.” Tributes from politicians and business-leaders Tribute from BBC website Tribute from Belfast Telegraph Find out more about the work of the McClay Foundation here. Watch our History, Culture and Values video to learn more about our background and vision for a successful future. Stay up-to-date with the latest from Almac Join our mailing list Contact Us Complete the form below and we will be in touch shortly… Confirm you have read and accepted the Almac Privacy Policy *By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to info@almacgroup.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list. Quick links Careers About Us Our Locations Latest News Knowledge Centre Almac Discovery Almac Diagnostic Services Privacy Policy Galen Pharmaceuticals Get in touch European Enquiries: +44 (0) 28 3833 2200 North American Enquiries: +1 (215) 660 8500 Asia Pacific Enquiries: +65 6309 0720 Social links linkedin twitter youtube vimeo RT @abcb_council: Well we knew he would win it! Congrats to Chief Executive Roger Wilson on winning @IoDNI 2021 Director of the Year Award… 1 hour ago ©2021 Almac Group Company Information Terms and Conditions Privacy & Cookie Policy Modern Slavery Statement By continuing to browse the site, you are agreeing to our use of cookies Agree